News

Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from May 1 2025. Pharmac’s Director ...
Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from 1 May 2025. Pharmac’s Director Pharmaceuticals, Geraldine MacGibbon, expects about 13,000 people with ...
The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes treatments Tresiba and Ryzodeg. The approval covers all 27 European Union member states. Tresiba ...
Pain-relief medication Zerodol SP saw a remarkable 22% growth, while other high-performing drugs like Ryzodeg, Rosuvas, Cilacar, Rybelsus, and Duphalac posted over 20% month-on-month growth ...
The Indian QR coding programme introduced in 2023 to detect counterfeit medicines will instead now cause great harm.